BusinessWeek - Exubera was supposed to revolutionize diabetes care. It was the first inhalable insulin product on the market, invented by biotech startup Nektar Therapeutics ( NKTR ) and shepherded to market by drug giant Pfizer ( PFE ), which predicted it would ...